Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Mar 2026 for Quest Diagnostics INC. Read the official filing
Filing timeline
BuySaleTimothy C. Wentworth
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Timothy C. Wentworth: trading record in brief
Timothy C. Wentworth (chief executive) discloses dealings in 3 companies, chiefly Walgreens Boots Alliance, Inc., Cigna Corp and Quest Diagnostics Inc. We count 6 filings; the first trade dates from 12 May 2021 and the latest from 9 March 2026.
The open-market record is one-sided, with 1 purchase worth €221k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants.
On 11 March 2026 came the latest disclosure, a share grant in Quest Diagnostics Inc. The most recent open-market purchase was published on 8 January 2024, 1,014 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Timothy C. Wentworth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
215 shares0Common StockSEC:0001252016-26-000004:0
1,332,014 sharesCommon StockSEC:0000950170-25-111920:0
762,032 shares0Common StockSEC:0001618921-24-000144:0
10,000 shares@ US$24.222100.0% of flowCommon StockSEC:0001618921-24-000006:0
Canonical exit: 4 Apr 2024 (T+90)
562,324 shares0Common StockSEC:0001618921-23-000101:0
11,150 shares0Common Stock, $.01 Par ValueSEC:0001225208-21-008125:0
6 of 6 declarations
